drugset / Trial / NCT06971965
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
Not yet recruiting
578 enrolled
National Cancer Center, Korea
Seoul National University Bundang Hospital · collabSeoul National University Hospital · collab
RandomizedParallel-groupOpen-labelHealth-services research
Summary
This study is a multicenter randomized controlled trial conducted in Korea. A parallel, two-group randomized design will be with thyroid stimulating hormone suppression therapy group(low TSH group; intervention) is different from the wIthout thyroid stimulating hormone (TSH) suppression therapy group(high TSH group; control).
Timeline
- Start
- 2025-06-02
- Primary completion
- 2027-12-31
- Completion
- 2032-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levothyroxine | Other / unclassified | — | Oral |